2026-06-29T02:48:01Zhttps://docta.ucm.es/rest/oai/request

oai:docta.ucm.es:20.500.14352/1303502026-01-16T01:02:30Zcom_20.500.14352_14col_20.500.14352_15

Antibiotic use in the COVID-19 crisis in Spain González Zorn, Bruno Before the coronavirus disease 2019 (COVID-19) pandemic, antimicrobial resistance was the world`s most pressing health crisis. The United Nations, the World Health Organization (WHO) and the European Center for Disease Control and Prevention have made antimicrobial resistance a top priority, establishing a task force in the G-20 and organizing a joint program initiative on antimicrobial resistance including countries from al over the world [1]. However, with the emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus pandemic in January 2020, all efforts are now focused on COVID-19, including controlling infections and developing vaccines 2026-01-15T14:44:55Z 2026-01-15T14:44:55Z 2021 journal article Gonzalez-Zorn B. (2021). Antibiotic use in the COVID-19 crisis in Spain. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 27(4), 646–647. https://doi.org/10.1016/j.cmi.2020.09.055 1198-743X 10.1016/j.cmi.2020.09.055 https://hdl.handle.net/20.500.14352/130350 1469-0691 https://doi.org/10.1016/j.cmi.2020.09.055 33248926 eng http://creativecommons.org/licenses/by/4.0/ open access Attribution 4.0 International Elsevier